Combining (preclinical) imaging and targeted therapy, is the basis of theranostics. In this webinar, Dr. Florea will highlight several studies performed at RWTH Aachen, where SPECT-CT non-invasive imaging was used to evaluate theranostic compounds.

Ionizing radiation approaches are effective but use of radioactive radioisotopic elements have become difficult to employ due to safety and security concerns. Current international standards point towards radioactive sources for viral inactivation.

Preclinical imaging (PCI) plays a vital role in understanding the biological processes behind disease states at the organ, tissue, cell and molecular level. 

fMRI studies often involve the electrical stimulation of i.e. the forepaw, detecting where this stimulation is registered in the brain via modifications in blood oxygen level dependent (BOLD) signal.

Spectral Instrument Imaging just announced a new, strategic partnership with InVivo Analytics, which enables quantitative analysis of bioluminescent reporter distributions across different animals, entire cohorts and study time points.

By combining study design, study management, and image analytics in all major imaging modalities, BioLaurus has conducted critical preclinical and clinical stage drug development studies.

Image guided radiotherapy in a preclinical setting couldn’t be more useful than the treatment of brain tumors, where normal tissue damage can have severe and long lasting effects.